Actively Recruiting
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
Led by University of Wisconsin, Madison · Updated on 2026-03-04
20
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days
CONDITIONS
Official Title
CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Over 18 years of age
- History of supra-sacral spinal cord injury of any cause
- Urinary incontinence with two or more episodes per day outside of spinal shock
- Willingness to participate in the drug intervention trial
- English-speaking and able to provide consent and complete questionnaires
You will not qualify if you...
- History of intravesical Botox treatment
- Currently taking more than 15 mg of Oxybutynin single dose or equivalent anticholinergic medication for bladder symptoms
- Use of cannabis in any form outside of study within one month before screening
- Presence of thought or mood disorder other than depression
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Wisconsin - Madison
Madison, Wisconsin, United States, 53705
Actively Recruiting
Research Team
M
Maria Flory
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here